Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study15

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study9

Views

Views
December 20230
January 20246
February 20241
March 20240
April 20240
May 20242
June 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
 

Top cities views

Views
Boardman6
Ashburn1
Chicago1
Fort Worth1